Search alternatives:
point decrease » point increase (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
19781
Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice
Published 2013“…</p><p>Methods</p><p>We evaluated whether hyperlipidemia modulates Klotho expression in kidneys from C57BL/6 and hyperlipidemic apolipoprotein E knockout (ApoE KO) mice fed with a normal chow diet (ND) or a Western-type high cholesterol-fat diet (HC) for 5 to 10 weeks, respectively.…”
-
19782
-
19783
-
19784
Advancing the science of NOWS research.
Published 2024“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
-
19785
Protocol measures.
Published 2024“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
-
19786
Cry variables.
Published 2024“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
-
19787
-
19788
-
19789
-
19790
-
19791
Treatment with anti-JAM-C antibody decreases neutrophil infiltration into the joints during antigen-induced arthritis
Published 2011“…In the right panels, leukocyte infiltration per field was evaluated by semi-quantitative scoring for anti-JAM-C antibody-treated (= 6, black columns) and isotype-matched control antibody-treated (= 5, open columns) mice. There was a significant decrease in synovial neutrophil infiltration in anti-JAM-C antibody-treated mice as compared to isotype-matched antibody-treated controls. *< 0.05 versus control mice, as assessed by analysis of variance. …”
-
19792
-
19793
-
19794
-
19795
-
19796
Unusual Pressure-Induced Self-Trapped Exciton to Free Exciton Transfer in Chiral 2D Lead Bromide Perovskites
Published 2024“…The phenomenon of pressure-induced emission alterations related to complex excitonic dynamics in 2D lead halide perovskites (LHPs) has gained considerable attention for understanding their structure–property relationship and obtaining inaccessible luminescence under ambient conditions. …”
-
19797
Unusual Pressure-Induced Self-Trapped Exciton to Free Exciton Transfer in Chiral 2D Lead Bromide Perovskites
Published 2024“…The phenomenon of pressure-induced emission alterations related to complex excitonic dynamics in 2D lead halide perovskites (LHPs) has gained considerable attention for understanding their structure–property relationship and obtaining inaccessible luminescence under ambient conditions. …”
-
19798
Table4_Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients.XLSX
Published 2021“…We have newly identified systemic site-specific N-glycosylation alterations underlying T2D patients in the complement activation pathways, including decreased levels of N-glycopeptides from C1s, MASP1, and CFP proteins, and increased levels of N-glycopeptides from C2, C4, C4BPA, C4BPB, and CFH. …”
-
19799
The effects of forskolin on NF-κB expression in LPS-treated RT4-D6P2T cells.
Published 2024“…<p>The immortalized rat RT4-D6P2T Schwann cell line (ATCC #CRL-2768) was treated with 0.1, 1, or 10 μg/mL of LPS in N<sub>2</sub> media, with or without 2 μM of forskolin (+/- Fsk), for 3 hours. …”
-
19800
Table1_Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients.XLSX
Published 2021“…We have newly identified systemic site-specific N-glycosylation alterations underlying T2D patients in the complement activation pathways, including decreased levels of N-glycopeptides from C1s, MASP1, and CFP proteins, and increased levels of N-glycopeptides from C2, C4, C4BPA, C4BPB, and CFH. …”